(Q34167925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Immunity against cancer: lessons learned from melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A N Houghton

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

N E Blachere

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Immunology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

134-140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

MAGE-B5, MAGE-B6, MAGE-C2, andMAGE-C3: four new members of theMAGE family with tumor-specific expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Tumor immunity and autoimmunity induced by immunization with homologous DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Coupling and uncoupling of tumor immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Fc receptors are required in passive and active immunity to melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillanc

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

Heteroclitic immunization induces tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900195-3

7 January 2021

10.1016/S0952-7915(00)00195-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11228404%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference